Agios Pharmaceuticals AGIO Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's common stock?
- Agios Pharmaceuticals (AGIO) reported common stock of $76K in Q1 2026.
- How has Agios Pharmaceuticals's common stock changed year-over-year?
- Agios Pharmaceuticals's common stock increased by 2.7% year-over-year, from $74K to $76K.
- What is the long-term trend for Agios Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's common stock has grown at a 1.7% compound annual growth rate (CAGR), from $69K to $75K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).